These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29191386)

  • 21. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
    J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression.
    Han LL; Yin XR; Zhang SQ
    Cell Physiol Biochem; 2018; 51(3):1179-1192. PubMed ID: 30481780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
    Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
    Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1.
    Li B; Liu L; Li X; Wu L
    Biochem Biophys Res Commun; 2015 Sep; 464(4):982-987. PubMed ID: 26163260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
    Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
    Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
    Sun X; Liu Y; Li M; Wang M; Wang Y
    Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
    Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP
    Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.
    Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
    Biomed Pharmacother; 2016 Apr; 79():315-20. PubMed ID: 27044843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.
    Chen SP; Liu BX; Xu J; Pei XF; Liao YJ; Yuan F; Zheng F
    BMC Cancer; 2015 Oct; 15():706. PubMed ID: 26471185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells.
    Wang J; Yang X; Ruan B; Dai B; Gao Y; Duan J; Qu S; Tao K; Dou K; Li H
    Tumour Biol; 2015 Apr; 36(4):2447-56. PubMed ID: 25412960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
    Shen G; Lin Y; Yang X; Zhang J; Xu Z; Jia H
    BMC Cancer; 2014 Jun; 14():393. PubMed ID: 24890815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.
    Wang T; Xu L; Jia R; Wei J
    Acta Biochim Biophys Sin (Shanghai); 2017 May; 49(5):383-391. PubMed ID: 28369267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression.
    Zhang Y; Li T; Guo P; Kang J; Wei Q; Jia X; Zhao W; Huai W; Qiu Y; Sun L; Han L
    Sci Rep; 2014 Sep; 4():6248. PubMed ID: 25175916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
    Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
    Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
    Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
    Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-93 enhances hepatocellular carcinoma invasion and metastasis by EMT via targeting PDCD4.
    Ji C; Liu H; Yin Q; Li H; Gao H
    Biotechnol Lett; 2017 Nov; 39(11):1621-1629. PubMed ID: 28748353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-suppressive miR-3650 inhibits tumor metastasis by directly targeting NFASC in hepatocellular carcinoma.
    Wu J; Huang WJ; Xi HL; Liu LY; Wang ST; Fan WZ; Peng BG
    Aging (Albany NY); 2019 Jun; 11(11):3432-3444. PubMed ID: 31163018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.